The study to explore the effecs of miglitol and sitagliptin on the responses of active gastric inhibitory polypeptide responses and the changes in body weight and visceral fat mass in type 2 diabetic patients with obesity

Trial Profile

The study to explore the effecs of miglitol and sitagliptin on the responses of active gastric inhibitory polypeptide responses and the changes in body weight and visceral fat mass in type 2 diabetic patients with obesity

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2014

At a glance

  • Drugs Miglitol (Primary) ; Sitagliptin (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms MASTER
  • Most Recent Events

    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 31 Mar 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top